A/s Novo, 10% Owner at Flexion Therapeutics Inc (FLXN), sold 150,000 shares at $20.07 ($3.1M) on 2015-06-19, disclosed to the SEC on 2015-06-22.
Open-market sale of $3.1M FLXN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.51 | 35,700 | $768K | 24.8% |
| 2 | $20.07 | 50,888 | $1.0M | 33.0% |
| 3 | $20.55 | 63,412 | $1.3M | 42.1% |
| Total | $20.62 avg | 150,000 | $3.1M | 100% |
| Filing → |
| RETA | SELL | 2017-06-12 | $5.7M | — | Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |